Dr. Rania Abou Elenein, MD

Dr. Abou Elenein practices at Methodist Associates in Healthcare, Inc in Huntingdon Valley, Pennsylvania.

Dr. Abou Elenein's NPI, 1114156866, was assigned on July 2, 2009. Dr. Abou Elenein holds Indiana license 01073417A.

Dr. Abou Elenein's primary practice is Methodist Associates in Healthcare, Inc, at 3501 Masons Mill Rd, Huntingdon Valley, PA 19006 in Montgomery County. The practice phone is (215) 952-9936.

Dr. Abou Elenein's primary practice is Methodist Associates in Healthcare, Inc in Huntingdon Valley, Pennsylvania. Dr. Abou Elenein is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson Community Physicians. Dmand AI also links Dr. Abou Elenein to 4 more hospitals, 4 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abou Elenein practices, 7 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Abou Elenein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Abou Elenein is licensed in Indiana.

CMS data shows 421 Medicare services from Dr. Abou Elenein across 10 procedure codes in 2024, for 269 Medicare patients. Medicare paid $33,980 for them. Every service was in an office.

CMS counts 269 Medicare patients who saw Dr. Abou Elenein in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abou Elenein's median patient age at 65, with 60% women.

In 2024, Dr. Abou Elenein wrote 856 Medicare Part D claims for 263 patients. 93% of them were for generic drugs. CMS names the drug for 737 of them, across 22 drugs with 11 or more claims each, at $541,250 in total drug cost. In 2023, CMS named 1,231 claims across 25 drugs.

Dr. Abou Elenein accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abou Elenein as offering telehealth. CMS counts 50 procedures of skin biopsy by Dr. Abou Elenein, more than 69% of the clinicians it reports for that procedure.

CMS Open Payments shows 140 general payments to Dr. Abou Elenein from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 81% of the total. LivaNova PLC paid the most, $725.